Lopaschuk, G. D., & Verma, S. (2020). Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: A State-of-the-Art Review. JACC. Basic to translational science, 5(6), 632-644. https://doi.org/10.1016/j.jacbts.2020.02.004
Citácia podle Chicago (17th ed.)Lopaschuk, Gary D., a Subodh Verma. "Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: A State-of-the-Art Review." JACC. Basic to Translational Science 5, no. 6 (2020): 632-644. https://doi.org/10.1016/j.jacbts.2020.02.004.
Citácia podľa MLA (8th ed.)Lopaschuk, Gary D., a Subodh Verma. "Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: A State-of-the-Art Review." JACC. Basic to Translational Science, vol. 5, no. 6, 2020, pp. 632-644, https://doi.org/10.1016/j.jacbts.2020.02.004.